Skip to main content
Khuloud T. Al-Jamal

Professor Khuloud Al-Jamal

Professor of Drug Delivery & Nanomedicine and Head of Medicines Development

Research interests

  • Pharmacology

Biography

Professor Khuloud T. Al-Jamal is a Chair of Drug Delivery & Nanomedicine, King’s College London. She is also a registered pharmacist at the General Pharmaceutical Council. She started her academic career as a lecturer at King’s College London in 2011. She completed her pre-registration pharmacy training at The University College London Hospital and was awarded the Overseas Research Award Scheme (ORSA) Scholarship from The University of London (2000-2004) to complete her PhD in Drug Delivery from The School of Pharmacy, University of London (currently known as UCL-School of Pharmacy). She was awarded the prestigious CW Maplethorpe Research and Teaching Postdoctoral Fellowship from The University of London (2005-2007) to explore the use of cationic dendrimers as anti-angiogenic agents for growth inhibition of solid and metastatic tumours.   She has developed an extensive experience in designing and developing novel nanoscale delivery systems including dendrimers, liposomes, quantum Dots (QDs), polymers, viral vectors, chemically functionalised carbon nanotubes and graphene oxide. Her current work involves pre-clinical translation of novel nanomaterials designed specifically for drug, protein, nucleic acids and radionuclide delivery for therapeutic or diagnostic applications.

She was awarded and is managing a number of research projects funded by The Royal Society, Worldwide Cancer Research, EPSRC, BBSRC, FP6, FP7 and ITN Marie Curie research programmes. In February 2012, she was awarded the BBSRC New Investigator award exploring the use of chemically functionalised carbon nano-needles as vectors for delivering therapeutics across the BBB. In 2012, she was awarded the prestigious Royal Pharmaceutical Society Science Award in recognition for her outstanding scientific achievements in the field of Nanomedicine. She is a three-time winner of the Wellcome Trust Image Award (2014-2016). 

    Research

    Medicines
    Medicines Development

    The Medicines Development Research Group develops novel materials, formulations, drug delivery devices, manufacturing, analytical, and digital technologies.

    LCN image-01
    London Centre for Nanotechnology

    The London Centre for Nanotechnology is a UK-based multidisciplinary enterprise operating at the forefront of science and technology. Its purpose is to solve global problems in information processing, healthcare, energy and the environment through the application of nanoscience and nanotechnology.

    OILRIG
    Lipids and Membranes Research Interest Group

    A Lipids and Membranes Research Interest Group

    News

    New stem cell-based therapy could treat liver fibrosis

    The new study demonstrates how mesenchymal stem cells can protect against, and reverse the damage from, liver fibrosis.

    Liver fibrosis

    Researchers look at enhancing brain delivery of drugs to treat neurodegenerative diseases

    New gel technology achieves enhanced brain delivery of a Parkinson’s Disease drug.

    nasal spray

    Using extracellular vesicles in the development of cancer therapeutics

    A collaboration between the School of Cancer & Pharmaceutical Sciences and pharmaceutical company, AstraZeneca, highlights promising advances in natural drug...

    cells

    Features

    5 minutes with Revadee Liam-Or

    Dr Revadee 'Ray' Liam-Or, based in the School of Cancer & Pharmaceutical Sciences, recently completed her PhD and is eager to develop her expertise in the...

    Research_impact_casepharmacy_thumb

    5 minutes with Khuloud Al-Jamal

    Khuloud Al-Jamal is Professor of Drug Delivery & Nanomedicine and Head of Medicines Development in the School of Cancer & Pharmaceutical Sciences.

    Medicine

      Research

      Medicines
      Medicines Development

      The Medicines Development Research Group develops novel materials, formulations, drug delivery devices, manufacturing, analytical, and digital technologies.

      LCN image-01
      London Centre for Nanotechnology

      The London Centre for Nanotechnology is a UK-based multidisciplinary enterprise operating at the forefront of science and technology. Its purpose is to solve global problems in information processing, healthcare, energy and the environment through the application of nanoscience and nanotechnology.

      OILRIG
      Lipids and Membranes Research Interest Group

      A Lipids and Membranes Research Interest Group

      News

      New stem cell-based therapy could treat liver fibrosis

      The new study demonstrates how mesenchymal stem cells can protect against, and reverse the damage from, liver fibrosis.

      Liver fibrosis

      Researchers look at enhancing brain delivery of drugs to treat neurodegenerative diseases

      New gel technology achieves enhanced brain delivery of a Parkinson’s Disease drug.

      nasal spray

      Using extracellular vesicles in the development of cancer therapeutics

      A collaboration between the School of Cancer & Pharmaceutical Sciences and pharmaceutical company, AstraZeneca, highlights promising advances in natural drug...

      cells

      Features

      5 minutes with Revadee Liam-Or

      Dr Revadee 'Ray' Liam-Or, based in the School of Cancer & Pharmaceutical Sciences, recently completed her PhD and is eager to develop her expertise in the...

      Research_impact_casepharmacy_thumb

      5 minutes with Khuloud Al-Jamal

      Khuloud Al-Jamal is Professor of Drug Delivery & Nanomedicine and Head of Medicines Development in the School of Cancer & Pharmaceutical Sciences.

      Medicine